Sidley Represents Capricor Therapeutics in US$23 Million Common Stock Offering

Sidley represented Capricor Therapeutics, Inc. in connection with the issuance and sale of 4,935,621 shares of common stock in a registered direct offering for estimated gross proceeds of approximately US$23 million. The shares were sold with a warrant to purchase one share of common stock exercisable six months after issuance and expiring seven years from the date of issuance.

The deal team was led by Rob R. Carlson, Nick DeAngelis, and Hannah M. Brown, and included Torrey Cope, Barbara Endres, Carlton Fleming, Dan O’Shea, Carla Teodoro, Jim Mendenhall, and Jen Fernandez.